Summary
Human immunodeficiency virus (HIV) 1 transgenic mice expressing low or undetectable levels of viral mRNA in lymphoid tissue were infected with the intracellular protozoan Toxoplasma gondii. Exposure to this parasite resulted in an increase in HIV-1 transcripts in lymph nodes, spleens, and lungs during the acute phase of infection and in the central nervous system during the chronic stage of disease. In vivo and ex vivo experiments identified macrophages as a major source of the induced HIV-1 transcripts. In contrast, T. gondii infection failed to stimulate HIV-1 transcription in tissues of two HIV-1 transgenic mouse strains harboring a HIV-1 proviral DNA in which the nuclear factor (NF) Kt3 binding moti~ from the viral long terminal repeats had been replaced with a duplicated Moloney murine leukemia virus core enhancer. A role for NF-KB in the activation of the HIV-1 by T. gondii was also suggested by the simultaneous induction of NF-KB binding activity and tumor necrosis factor c~ synthesis in transgenic mouse macrophages stimulated by exposure to parasite extracts. These results demonstrate the potential of an opportunistic pathogen to induce HIV-1 transcription in vivo and suggest a mechanism for the in vivo dissemination of HIV-1 by macrophages.
T
he progression towards AIDS in HIV-l-positive individuals appears to be directly related to HIV-1 replication and virus load in lymphoid tissues (1) (2) (3) . In vitro studies have demonstrated that activation of host immune cells (i.e., CD4 + T cells and macrophages) facilitates multiple steps of the virus life cycle (i.e., entry, integration, 1KNA synthesis, assembly, and/or release) in both primary and chronically infected cells (3) . Thus, stimulation of the immune system may have an important influence on viral replication and progression of disease in HIV-1 § individuals. HIV-1 induction is regulated at the transcriptional level by cis-elements in the 5' LT1K of integrated HIV-1 proviral DNA (4, 5) . Several mechanisms by which the HIV-1 LTIK can be activated and virus replication promoted have been demonstrated in vitro, a primary pathway involving the action of cytokines on infected host cells (3, (6) (7) (8) (9) (10) (11) (12) . Events that induce cytokine expression in vivo such as concomitant infections might, therefore, enhance HIV-1 transcription affecting the levels of cell-free and cell-associated virus and possibly accelerate the progression to AIDS (13) (14) (15) (16) .
Toxoplasma gondii, an opportunistic pathogen, is frequently associated with HIV-t infection, and is a common cause of encephalitis in AIDS patients (17, 18) . Previous studies have indicated that infection with this protozoan parasite induces strong cell-mediated immune responses (19) and that live tachyzoites as well as tachyzoite extracts can directly trigger human/mouse monocytes or macrophages to produce a series ofmonokines (GM-CSF, TNF-0L, IL-1, IL-6, and IL-12; 19-23) among which are known enhancers of HIV-1 expression in vitro (6) (7) (8) (9) (10) (11) . Indeed, recent experiments performed in our laboratories indicate that activation of human primary macrophages with T. gondii promotes the replication of a monotropic strain of HIV-I in vitro (24). In the present study, the ability of T. gondii to trigger Fig. 1 ). This replacement was originally designed to augment the very low levels of expression directed by the wild-type HIV-1 LTR in mouse cells or in previously described transgenic mice. In the present study, transgenic animals containing the MLV/HIV-I[ANF-KB] proviral DNA were used instead, as negative controls, to test the involvement of NF-KB binding sites within the HIV-1 LTR. on T. gondiiinduced viral mR.NA expression. These mice were generated using protocols described in detail elsewhere (29) . Briefly, PCILamplified MLV enhancer sequences were cloned into an Xbal site engineered by M13 mutagenesis at the position ofa NF-KB deletion in the wild-type HIV-1 LTP,. The recombinant proviral DNA was then assembled by the multiple ligation of genomic DNA fragments. The three transgenic lines stably transmitted their respective transgenes in Mendelian fashion (at 20-60 copies present at single integration sites) and expressed HIV-1 P, NA in multiple tissues including secondary lymphoid organs (25). Each proviral DNA encoded the full complement of HIV-1 genes and directed the synthesis of three size classes of viral mR.NAs corresponding to unspliced (gag/pol), singly spliced (vif, vpr, env) and multiply spliced (tat, rev, nef) HIV-1 transcripts (see Fig. 1 ). In contrast to the HIV-1 P, NA patterns commonly associated with acutely infected human lymphocytes but reminiscent of a R.ev-deficient phenotype (30) , HIV-1 P, NA in mouse tissue was often dominated by the presence of small molecular weight (2-kb class), multiply spliced transcripts. HIV-1 R.NA sizes differed slightly between the wild-type HIV-1 transgenic line 166 and the MLV/ HIV-I[ANF-KB] recombinant lines (Hm28 and Hm54) because of the presence of MLV enhancer sequences in the LT1< that elongated transcripts from the recombinant LTR by "~ bases (see Fig. 1 B) . Experiments were conducted in heterozygous and homozygous line 166 mice, whereas only heterozygous Hm28 and Hm54 mice were available for use since homozygous animals in the latter lines are nonviable. The cysts had been obtained from brains of donor mice infected at least 1 mo earlier as described previously (31) .
Materials and Methods

Derivation
Histopathology. At 8-10 (acute stage) or 50-70 d (chronic stage) postinfection animals were killed by cervical dislocation. The lungs and brains of each animal were separated into two lobes or halves, one of which was fixed in formalin for histopathology while the second was used for I<NA extraction (see below). After 24 h in formalin, the tissues were transferred to 70% ethanol before processing for paraftqn sections. The resulting slides were stained with hematoxylin and eosin (H&E) and the sections were evaluated microscopically as described previously (30) . To prepare inflammatory macrophages, peritoneal exudate cells were obtained 5 d after i.p. injection of 1.5 ml of 3% thioglycolate and plated at 2 • 106 cells/ml in 24-well flat-bottom plates (Costar Corp., Cambridge, MA). After 4 h of incubation (37~ 5% CO2), the nonadherent cells were removed and the macrophage-enriched monolayer was washed in warm medium (21, 22 obtained by sonication and centrifugation of tissue culturederived P,H strain tachyzoites as previously described (31) . To measure monokine responses and/or induction of HIV-1 proviral transcription, STAg (5 txg/ml), Escherichia coli LPS (23; 100 ng/ml), or TNF-~ (100 U/rnl; Genzyme Corp., Cambridge, MA) were added in 1 ml of medium (DMEM, 10% FCS, 2 mM glutamine, 100 U ml/penicillin, 100 },g/ml streptomycin, 25 mM Hepes, and 50 txM IS-ME) to monolayer wells in the presence of either control (GL-113 anti-13-galactosidase; 20 Ixg/ml) or anti-TNF-et (20 Ixg/ml) mAbs as indicated. The supernatant and adherent cells were obtained 8-12 h after stimulation for measurement of TNF-ot or detection of actin or HIV-1 mRNAs, respectively.
Cell Separation
RNA Preparation. RNA was isolated from cells and tissues us-
ing an adaptation of a published procedure (32) . Total splenocytes (10v), fractionated spleen cell populations (2 • 10% thioglycolate-elicited macrophages (2 • 106 before adherence), or ~200 mg of tissue (spleen, lung, or brain) were homogenized in 1 ml of ice-cold acid guanidiniunl thiocyanate solution buffer supplemented with B-ME (0.7%). After addition of 0.1 ml of 2 M sochum acetate, pH 4.0, 1.0 ml of water-saturated phenol, and 0.2 ml of chloroform, the samples were mixed vigorously and left on ice for 15 nfin. RNA was recovered in the aqueous phase after centrifugation (10,000 rpm at 4~ and precipitated in isopropanol as previously described (32) . The final RNA pellet was resuspended and stored frozen in water containing either 1 mM EDTA for reverse transcriptase (RT)-PCR or 0.2% SDS for Northern blot analysis. In some experiments, poly(A) I<NA was isolated from total RNA samples by oligo-dT cellulose chromatography. Electrophoretic Mobility Shift Assay. Nuclear extracts of peritoneal macrophages from FVB/N or HIV-1 transgenic mice unstimulated or simulated with either LPS (100 ng/ml), STAg (5 I.~g/ml), or TNF-(x (100 U/ml) were prepared as previously described (33) and assayed for the presence of NF-id3 binding activity by electrophoretic mobility shift assay (EMSA) (34) . Two double-stranded oligonucleotide probes were employed: a palindromic KB probe (PD-KB; 35) or an HIV-l-derived NF-~d3 binding motif (HIV-1-KB; 4). Approximately 0.4 p~g of nuclear extract was used in each binding reaction. Antibodies directed against NF-vd3 p65 protein, types C-20 or A (4 ~1 each; Santa Cruz Biotechnology Inc., Santa Cruz, CA) were employed in the supershift assays.
Northern Blot Analysis of Proviral
RT-PCR. 1 Ixg of total R N A obtained from either lung or brain of ilafected mice was reverse transcribed using MLV R T (GIBCO BRL, Gaithersburg, MD). The reaction mixture was then diluted 1:8 and 10 I~1 used for specific semi-quantitative amplification ofcytokine mlLNA using Taq DNA polymerase (Promega Corp., Madison, WI). Southern transfers of P C R products were subsequendy probed with internal cytokine-specific oligonucleotides and visualized using the ECL chemiluminescent detection system (Amersham International, Amersham, Bucks, UK). Nucleotide sequences for sense and antisense primers and probes for hypoxanthine phosphoribosyltransferase (HPR.T) 23, IL-1 27, IL-6 33, T N F -a 32, GM-CSF 35, and T. gondii-specific gene surface antigen (SAG-2) [40] have been previously described (21, 36) and the cycle numbers (indicated within the brackets) determined experimentally.
TNF-ot Assay. TNF-o~ was quantitated in 8-12-h supernatants of adherent peritoneal macrophage cultures by means of a cytotoxicity assay using TNF-sensitive L929 cells and murine rTNF-~x (Genzyme Corp.) as a standard (23).
Results
Increased HIV-1 mRNA Expression in Tissues of Transgenic Mice Infected with T. gondii. Infection with T. gondii ini-
tially manifests as an acute phase in which the tachyzoites (the rapidly multiplying stage of the parasite) are found in tissues accompanied by mononuclear inflammatory reactions leading to small necrotic loci. Parasite multiplication during this stage occurs preferentially in the liver, lungs, and lymphoid tissues (19, 37) . Paralleling the tissue tropism o f the parasite, expression of discrete HIV-l~pecific R N A s was elevated in the lungs, spleens and lymph nodes (Fig. 2, top and Fig. 3, left) of transgenic mice (line 166) carrying a complete copy of HIV-1 proviral D N A and analyzed during that period (10 d after T. gondii infection). HIV-1--specific transcripts were identified on the basis o f their size and comigration with HIV-1 R N A extracted from productively infected human cells (Fig. 3) . By comparison, there was only a modest increase in HIV-1 transcripts in splenic extracts from a second infected transgenic mouse line (Hm28) in which the NF-KB motifs in the L T R had been replaced with the core enhancer element from MLV whereas no HIV-1 R N A was detected in lung tissue removed from the same animals (Fig. 2) . Furthermore, identical results were obtained with a second independently derived transgenic line (Hm54) containing the MLV enhancer substitution (designated MLV/HIV-I[ANF-KB]) (data not shown).
Histopathological changes were evident in the lungs of acutely infected animals regardless o f strain (nontransgenic, HIV-1, or MLV/HIV-I[ANF-r,B] transgenic mice) and featured comparable levels of nodular infiltrates of lymphocytes and macrophages (generally ~7 0 gtm in diameter) as well as perivascular lymphocytic infiltrates (Fig. 4, left) . Increases in actin R N A in the lungs from all acutely infected animals ( Fig. 2, top) probably arise from these infiltrating inflammatory cells. However, it is important to note that the same difference in actin m R N A levels is seen in the lungs of control MLV/HIV-I[ANF-KB] transgenic mice with no increase in the appearance of viral transcripts. R N A extracted from lungs of infected mice also contained elevated levels (5-34-fold increases after normalization with H P R T (Fig. 4, right) .
After the development o f immunity, tachyzoites are cleared from host tissues and necrotic foci regenerate. The chronic phase of infection ensues and the parasite characteristically appears in the form ofbradyzoites contained within cysts found predominantly in the central nervous system. Occasionally tachyzoites may escape from cysts and probably boost the immune response that effectively controls the further dissemination of the parasite (19, 37) . Elevations in tachyzoite mR.NA were detected in brains of infected control or transgenic mice in the chronic phase (30--50 d) of infection (Fig. 5, right) . In contrast to the same tissues in acutely infected animals (data not shown), brains of chronically infected line 166 transgenic mice displayed marked increases inHIV-l-specific R N A (Fig. 2, bottom) . By 
Characterization of HIV-1 R N A and Identification of Cellular Source of HIV-1 Transcripts. HIV-l-related R N A was de-1649
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tected in spleens o f uninfected HIV-1 transgenic mice, but it was smeared and of no discrete size (Fig, 2 and cells, and 32% macrophages) harvested 10 d after infection were separated into T lymphocytes (>90% purity) and adherent cells (,'-'82% macrophages) and analyzed by FACS | as previously described (31) . As shown in Fig. 3 (right) ,
HIV-1 transcription in total splenocytes was detected in the macrophage-enriched adherent cell population but not in the T cell-enriched population.
Induction of HIV-1 Transcripts by T. gondii In Vitro.
The ability ofmacrophages from HIV-1 transgenic mice to express 
Role of TNF-ae and NF-KB in HIV-1 Expression Induced by T. gondii.
To examine mechanisms by which T. gondii could activate the HIV-1 L T R in the inflammatory macrophages from HIV-1 transgenic mice, we assayed culture media for the increased production o f TNF-o~ after the activation of macrophages. Transgenic macrophages were comparable to nontransgenic macrophages in their ability to produce and release TNF-o~ into the culture medium after STAg (Fig. 6  A, left) or LPS (data not shown) treatment. Comparable levels of TNF-o~ were produced by macrophages from either the wild-type HIV-1 or MLV/HIV-I[ANF-vd3] transgenic lines after activation with different stimuli. These results suggest that the inability of macrophages from M L V / HIV-I[ANF-v,.B] transgenic mice to express HIV-1 transcripts is not due to a generalized defect in activation and/ or TNF-oe synthesis by these cells. TNF-o~ is known to activate the HIV-1 L T R (7-11) in a variety o f different systems. Therefore, we cultured macrophages from the HIV-1 transgenic mice with different stimuli (i.e., STAg, LPS, or TNF-oe) in the presence of anti-TNF mAb. In vitro neutralization of T N F blocked the activation of HIV-1 transcription by T N F -a but only partially blocked STAg-or LPS-induced activation (Fig. 6 A, right) .
The ability of TNF-o~ to stimulate HIV-1 expression is attributed, at least in part, to the activation of NF-KB binding activity (7) . To further analyze this question, NF-cJ3 induction in control and activated macrophages from FVB/ N and the two types oftransgenic mice was measured in an EMSA (34) using double-stranded D N A oligonucleotide probes containing either a NF-KB consensus binding sequence (PD-KB; Fig. 6 C, right; 35) or an H I V -l -d e r i v e d NF-KB binding motif (HIV-1-KB; 4; Fig. 6 B, left) . Increased NF-~B binding activity in macrophages was observed when cells were stimulated with either STAg, LPS, or TNF-e~. The identification of NF-KB binding activity was confirmed in mobility shift assays by demonstrating the sensitivity of the binding complex to supershifting using commercial antibodies (types C-20 or A) directed against the p65 component of NF-KB (Fig. 6 B) . Under the conditions used, only the type A antibody cross-reacted with the murine NF-r component. The nonreactive antibody (C-20) was included as a negative control for nonspecific Ig binding. Similar levels of LPS-or STAg-stimulated NF-KI3 induction were observed in inflammatory macrophages derived from nontransgenic (Fig. 6 , B and C) and HIV-1 transgenic mice (Fig. 6 C) . Anti-TNF antibodies, while only partially blocking the activation of NF-KB by STAg and LPS, completely inhibited NF-KB induction by TNF-c~ (Fig. 6 B) . Thus, the induction of NF-rd3 and HIV-1 transcription in macrophages from HIV-1 transgenic mice ap-
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Discussion
In an attempt to develop an animal model to study HIV-1 pathogenesis and the function of viral genes in vivo, several lines oftransgenic mice have been constructed (25--27). These animals provide a model for the postintegration steps of the HIV-1 life cycle only. Any infectious virus progeny generated in transgenic mice harboring full-length copies of the viral genome would be unable to establish a spreading infection in the mouse for several reasons including: (a) the failure of HIV-1 to adsorb and enter lymphocytes bearing mouse CD4 (38) ; and (b) the relative inefficiency, in mouse cells, of the HIV-1--encoded Tat and R e v proteins to direct levels of steady state R N A and transport unspliced and singly-spliced viral R N A s from the nucleus to the cytoplasm, respectively (39) (40) (41) . Expression directed by the wildtype L T R in mouse cells or previously described transgenic mice is therefore very low (25-27). Futhermore, the pattern of HIV-1 expression in mouse cells (39) or most tissues from transgenic mice, as monitored by Northern blot hybridization, is reminiscent of a " R e v minus" phenotype, i.e., predominantly multiply spliced 2.0-kb transcripts and little full-length 9.2-and 4.0-kb singly spliced mRNAs. Nevertheless, depending on the degree of proviral expression, tissue origin of the samples, and possibly the extent of viral m R N A enrichment, the profile observed in the Northern blot may vary greatly. As shown in Fig. 1 , the three classes of HIV-1 R N A are clearly evident in samples puff- fled from the lens of the two transgenic mouse lines under study in this report. In contrast, expression directed by the wild-type LTR in most other mouse tissues is extremely low and the RNA species observed are frequently limited to the fully spliced 2-kb class (Fig. 2) .
In the present study, we have shown that in vivo infection with the opportunistic pathogen, T. gondii, leads to induction of HIV-1 mRNAs in tissues in which constitutive proviral expression is normally at the limit of detectability. The exposure of macrophages to parasite extracts in vitro enhances the level ofHIV-1 RNAs, arguing that these cells are likely to be a major target for parasite-induced proviral activation. It is interesting to note that, in addition to multiply spliced low molecular weight transcripts, singly spliced 4.2-and unspliced 9.0-kb viral mRNAs are evident in some T. gondii-exposed tissues, suggestive evidence of partial Rev function.
We postulate that infection of HIV-1 transgenic mice with T. gondii potentiates the expression of HIV-1 mRNA in inflammatory cells as shown ex vivo in macrophages. During Toxoplasma infection, infiltration of tissues (e.g., lungs and brain that normally display no or neglible levels of HIV-1 proviral expression) by inflammatory cells results in the synthesis of measurable levels of HIV-l-specific RNAs. These HIV-1 transcripts are likely to represent products of the cells migrating to the site of T. gondii infection rather than those preexisting in the tissue. The latter concept also suggests that a pathogen-induced inflammatory response may play an important role in increasing HIV-1 levels in specific tissue sites. Similar phenomena may occur during infection with other opportunistic pathogens, such as Mycobacterium tuberculosis (42) (43) (44) or M. avium (45) which also possess the ability to attract and activate macrophages into the infection site and therefore would promote HIV-1 expression and viral spread in vivo.
The data presented here also suggest that NF-K]3 induction plays a central role in the activation of HIV-1 transcription in macrophages from HIV-1 transgenic mice by T. gondii. The failure to activate HIV-1 transcription in macrophages from two independent MLV/HIV-I[ANF-KI3] transgenic mouse lines lacking NF-KB binding sites is consistent with the requirement of NF-KB activity for in vivo activation of the HIV-1 LTR during infection with T. gondii. Furthermore, ex vivo activation experiments performed in the presence of anti-TNF antibodies suggest that both TNF-oL-dependent (7-11) and -independent mechanisms are involved in the HIV-1 LTR activation by T. gondii since neutralization of that cytokine caused only a minor inhibition in STAg-induced proviral transcription. The existence of TNF-independent mechanisms was also suggested by previous studies (46) indicating that direct exposure of a chronically infected monocytoid cell line to LPS or PMA results in an augmentation of HIV-1 replication in the absence of TNF-o~.
Since toxoplasmosis can be associated with HIV-1 infection (17, 18) , the results presented here imply that activation of macrophages by tachyzoites (during acute infection and/or reactivation of chronic disease) may augment viral gene expression and virus replication and lead to increased virus loads in HIV-l-seropositive individuals. However, to the best of our knowledge there is only one study suggesting that T. gondii m ay act as an HIV-1 cofactor. In the latter report, increased congenital transmission of HIV-1 was observed in children of T. gondii-infected mothers (47) .
Studies specifically evaluating HIV-1 progression in individuals infected with the protozoan are necessary to validate this hypothetical disease interaction.
A major limitation in studying the influence of coinfections on the activation of HIV-1 in vivo, and therefore on AIDS pathogenesis, is the absence of a suitable animal model. The results presented here suggest that transgenic mice containing the complete wild-type HIV-1 proviral DNA may serve as useful tools for investigating these phenomena as well as for testing effective therapies for the prevention or repression of HIV-1 transcription in vivo. Two important attributes of these transgenic mice are the induceability of HIV-1 gene expression in macrophages, and that the initiation and/or augmentation of viral transcription in macrophages appears to be under the control of the wildtype HIV-1 LTR. In humans, macrophages represent a major reservoir for HIV-1. Thus, the activation of HIV-1-infected macrophages resulting in transcription of HIV-1 genes and viral replication could be an important element affecting disease progression (48) (49) (50) (51) . The HIV-1 transgenic mouse model described here should provide a useful tool for studying pathways responsible for HIV-1 induction in macrophages in vivo as well as for evaluating treatments that inhibit this potentially important mechanism of AIDS pathogenesis.
